Breakthrough gene therapy allows 11-year-old boy to hear for the first time
Wednesday, 24 January 2024 Aissam Dam, an 11-year-old boy born deaf, underwent a successful clinical trial for gene therapy to treat his congenital deafness. The therapy aims to replace the mutated otoferlin gene with a functional one. This groundbreaking study, supported by Eli Lilly, could pave the way for gene therapies targeting other forms of congenital deafness.
Join us this Wednesday, January 24 at 11AM Pacific Time — on RUMBLE ONLY — as Steve Shultz interviews Gene Ho for a special broadcast of "Prophets and Patriots.” Gene will be discussing his personal relationship with President Trump, insights regarding JFK Jr., living out prophetic...
Billy Joel , Will Perform at the Grammys.
Joel was announced as a performer
on Jan. 24, 'Rolling Stone' reports.
Joel was announced as a performer
on Jan. 24, 'Rolling Stone' reports.
The last..
Credit: Wibbitz Top Stories Duration: 01:30Published
A child with hereditary deafness regained their hearing thanks to a successful gene therapy surgery. 11-year-old Aissam Dam became the first person to get gene therapy in the United States for..
Join us this Wednesday, January 24 at 11AM Pacific Time — on RUMBLE ONLY — as Steve Shultz interviews Gene Ho for a special broadcast of "Prophets and Patriots.” Gene will be discussing..